Your browser doesn't support javascript.
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.
Waghmare, Alpana; Abidi, Maheen Z; Boeckh, Michael; Chemaly, Roy F; Dadwal, Sanjeet; El Boghdadly, Zeinab; Kamboj, Mini; Papanicolaou, Genovefa A; Pergam, Steven A; Shahid, Zainab.
  • Waghmare A; University of Washington, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: awaghmar@fredhutch.org.
  • Abidi MZ; University of Colorado Denver, Denver, Colorado.
  • Boeckh M; University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Chemaly RF; University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dadwal S; City of Hope National Medical Center, Duarte, California.
  • El Boghdadly Z; The Ohio State University Medical Center/The James Cancer Center and Solove Research Institute, Columbus, Ohio.
  • Kamboj M; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Papanicolaou GA; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
  • Pergam SA; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington.
  • Shahid Z; Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
Biol Blood Marrow Transplant ; 26(11): 1983-1994, 2020 11.
Article in English | MEDLINE | ID: covidwho-692782
ABSTRACT
There are currently limited data on the epidemiology, clinical manifestations, and optimal management of Coronavirus Disease 2019 (COVID-19) in hematopoietic cell transplantation and cellular therapy recipients. Given the experience with other respiratory viruses, we anticipate that patients may develop severe clinical disease and thus provide the following general principles for cancer centers across the nation. These guidelines were developed by members of the American Society for Transplantation and Cellular Therapy Infectious Diseases Special Interest Group. Specific practices may vary depending on local epidemiology and testing capacity, and the guidance provided in this document may change as new information becomes available.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adrenal Cortex Hormones / Hematopoietic Stem Cell Transplantation / COVID-19 / COVID-19 Drug Treatment / Immunologic Factors / Neoplasms Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Biol Blood Marrow Transplant Journal subject: Hematology / Transplantation Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adrenal Cortex Hormones / Hematopoietic Stem Cell Transplantation / COVID-19 / COVID-19 Drug Treatment / Immunologic Factors / Neoplasms Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Biol Blood Marrow Transplant Journal subject: Hematology / Transplantation Year: 2020 Document Type: Article